Pulmonary Medicine
HSV type 1 thymidine kinase/ganciclovir gene therapy targets lung cancer
Published in Gene Therapy Weekly, May 27th, 2004
According to a study from Finland, "lung cancer is a group of diseases that are difficult to cure and new treatment modalities, like gene therapy are actively tested to find alternatives for currently used strategies. Herpes simplex virus thymidine kinase/ganciclovir (HSV-TK/GCV) method is one of the most frequently utilized forms of gene therapy and it has been tested on lung cancer, but no systematic study with comparison of different lung cancer types has been published."
"In this study, we examined in vitro and in vivo how good targets non-small cell lung cancer (NSCLC)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2004-05-27)
More Articles from Gene Therapy Weekly
- Cancer Therapy
Clostridia spores offer a natural alternative for tumor targeting - Epilepsy
Neuropeptide Y transfection diminishes epileptic activity in rats - Transfection
Single-step surfection eases gene transfer and drug screening - Virology
Adenovirus vector libraries provide clues about gene and protein function - Alcoholism
Gene therapy reduces drinking in rats with predisposition to alcohol abuse - Angiology
Autologous vascular smooth muscle cells are a conduit for cardiac gene transfer - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
